Evidence map›Paper›PMID 41871294›Full record

ArticleHuman molecular genetics2026

A reanalysis of a genome-wide association study on breast cancer in Asian populations using the SG10K_Health reference panel for imputation: a multi-Centre case-control analysis.

Xuling Chang, Shivaani Mariapun, Mengyu Li, Ling Wang, Peh Joo Ho, Alexis Jiaying Khng, Kenneth R Muir, Artitaya Lophatananon, Kristan J Aronson, Rachel A Murphy and 32 more

Abstract readMulticenter Study
In one paragraph

Article in Human molecular genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors.

Xuling ChangDepartment of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Melbourne VIC 3000, Australia.
Shivaani MariapunCancer Research Malaysia, Level 1, Subang Jaya Medical Centre South Tower, 1, Jalan SS12/1A, Ss 12, 47500 Subang Jaya, Selangor, Malaysia.
Mengyu LiGenome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), 60 Biopolis St, Genome, #02-01, Singapore 138672, Singapore.
Ling WangGenome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), 60 Biopolis St, Genome, #02-01, Singapore 138672, Singapore.
Peh Joo HoGenome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), 60 Biopolis St, Genome, #02-01, Singapore 138672, Singapore.
Alexis Jiaying KhngGenome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), 60 Biopolis St, Genome, #02-01, Singapore 138672, Singapore.
Kenneth R MuirDivision of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, 46 Grafton Street, Manchester M13 9NT, United Kingdom.
Artitaya LophatananonDivision of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, 46 Grafton Street, Manchester M13 9NT, United Kingdom.
Kristan J AronsonDepartment of Public Health Sciences and Sinclair Cancer Research Institute, Queen's University, 355 King St. West, Kingston, ON K7L 2X3, Canada.
Rachel A MurphySchool of Population and Public Health, University of British Columbia, 2206 East Mall, Vancouver, BC V6T 1Z3, Canada.
Ava KwongHong Kong Hereditary Breast Cancer Family Registry, 6/F, No. 3 Tung Wong Road, Shau Kei Wan, Hong Kong.
Chun Hang AuMolecular Pathology Division, Department of Pathology, Hong Kong Sanatorium and Hospital, 2 Village Rd, Happy Valley, Hong Kong.
Sung-Won KimDepartment of Surgery, 657 Siheung-daero, Yeongdeungpo District, Seoul, Republic of Korea.
Sue K ParkDepartment of Preventive Medicine, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea.ORCID 0000-0001-5002-9707
Daniel O StramDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Ave, Los Angeles, CA 90033, USA.
Anna H WuDepartment of Population Health and Public Health Sciences, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, 1441 Eastlake Ave, Los Angeles, CA 90033, USA.
Soo-Hwang TeoCancer Research Malaysia, Level 1, Subang Jaya Medical Centre South Tower, 1, Jalan SS12/1A, Ss 12, 47500 Subang Jaya, Selangor, Malaysia.
Cheng-Har YipSime Darby Medical Centre, No. 1, Jalan SS 12/1A, Ss 12, 47500 Subang Jaya, Selangor, Malaysia.
Nur Aishah Mohd TaiDepartment of Surgery, Faculty of Medicine, University of Malaya, UM Cancer Research Institute, Kuala Lumpur 50603, Malaysia.
MyBrCa Investigators
Esther M JohnDepartment of Epidemiology and Population Health, Stanford University School of Medicine, Alway Building, 300 Pasteur Drive, Stanford, CA 94305, USA.
Allison W KurianDepartment of Epidemiology and Population Health, Stanford University School of Medicine, Alway Building, 300 Pasteur Drive, Stanford, CA 94305, USA.ORCID 0000-0002-6175-9470
Motoki IwasakiDivision of Epidemiology, National Cancer Center Institute for Cancer Control, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.ORCID 0000-0003-3319-4131
Taiki YamajiDivision of Epidemiology, National Cancer Center Institute for Cancer Control, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.ORCID 0000-0002-4799-8782
Ji-Yeob ChoiCancer Research Institute, Seoul National University, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea.
Daehee KangDepartment of Preventive Medicine, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea.ORCID 0000-0003-4031-5878
Xiao-Ou ShuDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, Suite 600 (IMPH), Nashville, TN 37203-1738, USA.
Wei ZhengDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, Suite 600 (IMPH), Nashville, TN 37203-1738, USA.
Mikael HartmanSaw Swee Hock School of Public Health, National University of Singapore and National University Health System, 12 Science Drive 2, #10-01, Singapore 117549, Singapore.
Ern Yu TanDepartment of General Surgery, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Level 2, TTSH Medical Centre, Singapore 308433, Singapore.
Veronique Kiak-Mien TanDivision of Surgery and Surgical Oncology, National Cancer Centre Singapore, 30 Hospital Boulevard, Singapore 168583, Singapore.
Geok Hoon LimSingHealth Duke-NUS Breast Centre, Singapore Health Services (SingHealth), 5 Hospital Drive, Singapore 169609, Singapore, Singapore.
Manjeet K BollaCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CambridgeWorts Causeway, Cambridge, CB1 8RN, United Kingdom.ORCID 0000-0002-4351-9326
Alison M DunningCentre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, CambridgeWorts Causeway, Cambridge, CB1 8RN, United Kingdom.ORCID 0000-0001-6651-7166
Joe DennisCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CambridgeWorts Causeway, Cambridge, CB1 8RN, United Kingdom.ORCID 0000-0003-4591-1214
Qin WangCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CambridgeWorts Causeway, Cambridge, CB1 8RN, United Kingdom.ORCID 0000-0002-9139-0627
Marc NavenCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CambridgeWorts Causeway, Cambridge, CB1 8RN, United Kingdom.
Douglas F EastonCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CambridgeWorts Causeway, Cambridge, CB1 8RN, United Kingdom.ORCID 0000-0003-2444-3247
SG10K_Health Consortium
Rajkumar S/O Dorajoo *Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, NUHS Tower Block, Level 12, Singapore 119228, Singapore.
Weang-Kee Ho *School of Mathematical Sciences, Faculty of Science and Engineering, University of Nottingham Malaysia, Jalan Broga, 43500 Semenyih, Selangor Darul Ehsan, Malaysia.
Jingmei Li *Genome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), 60 Biopolis St, Genome, #02-01, Singapore 138672, Singapore.ORCID 0000-0001-8587-7511

Funding

PRECISION Health Research, Singapore (PRECISE CIP)Wellcome TrustWellcome Trust Career Development Award 227824/Z/23/Z (UNS146816)
6 · The paper itself

Abstract

Genome-wide association studies (GWAS) have identified numerous genetic variants linked to breast cancer risk, but most discoveries come from European populations, limiting their applicability to other populations. Here, we show that the choice of genotype imputation reference panel, an essential step for GWAS, affects variant detection in Asian populations. Using two large breast cancer datasets from the Breast Cancer Association Consortium (n = 38 954 Asian samples), we compared the 1000 Genomes (1KG) reference panel with SG10K_Health (SG10K), an Asian-specific panel. SG10K imputed more rare variants and achieved higher accuracy for rare alleles (MAF < 0.001), while 1KG performed better for common variants in some contexts. Differences in panel performance influenced association signals, including breast cancer candidate loci such as FGFR2, TOX3, and ESR1. Together, these findings support the use of population-specific imputation panels as a means to improve variant discovery in underrepresented populations.

Indexed as

Asian PeopleBreast NeoplasmsGenome-Wide Association StudyAllelesApoptosis Regulatory ProteinsCase-Control StudiesEstrogen Receptor alphaFemaleGenetic Predisposition to DiseaseGenotypeHumansPolymorphism, Single NucleotideReceptor, Fibroblast Growth Factor, Type 2Trans-ActivatorsApoptosis Regulatory ProteinsESR1 protein, humanEstrogen Receptor alphaFGFR2 protein, humanReceptor, Fibroblast Growth Factor, Type 2TOX3 protein, humanTrans-ActivatorsAsian ancestrybreast neoplasmsgenome-wide association studygenotype imputationreference panels

Identifiers

PMID41871294
PMCPMC13017919

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.